{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:58:49Z","timestamp":1794704329026,"version":"4.9.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National Key R&amp;D Program of China","award":["2018YFC1312902"],"award-info":[{"award-number":["2018YFC1312902"]}]},{"name":"Science and Technology Innovation Platform of Jiangxi Department of Science and Technology","award":["20171BCD40024"],"award-info":[{"award-number":["20171BCD40024"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The association between cytochrome P450 2C19 (CYP2C19) polymorphisms and neurological deterioration in stroke or transient ischemic attack (TIA) patients is not completely understood. Hence, we performed a systematic review and meta-analysis of prospective cohort studies to quantify this association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed, Cochrane Library, Excerpta Medica Database, China National Knowledge Infrastructure and WanFang databases were searched for studies published up to April 2019. Prospective cohort studies that reported an association between CYP2C19 polymorphisms and neurological deterioration in stroke\/TIA patients were included. Data on risk ratio (RR) and 95% confidence intervals (CI) were extracted and pooled by the authors. Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were followed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twelve eligible studies were included. Twelve studies reported CYP2C19\u22172, \u22173 loss-of-function alleles and 5 studies reported CYP2C19\u221717 gain-of-function allele. Compared to non-carriers, carriers of CYP2C19\u22172, \u22173 loss-of-function alleles had a significantly higher risk of neurological deterioration (RR, 1.63; 95%CI, 1.32\u20132.02). Conversely, carriers of CYP2C19\u221717 gain-of-function allele had a significantly lower risk of neurological deterioration (RR, 0.520; 95%CI, 0.393\u20130.689) compared to non-carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This meta-analysis demonstrated that the carriers of CYP2C19\u22172, \u22173 loss-of-function alleles have an increased risk of neurological deterioration compared to non-carriers in stroke or TIA patients. Additionally, CYP2C19\u221717 gain-of-function allele can reduce the risk of neurological deterioration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000025150","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T18:02:02Z","timestamp":1615917722000},"page":"e25150","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Does CYP2C19 polymorphisms affect neurological deterioration in stroke\/TIA patients?"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9751-2376","authenticated-orcid":false,"given":"Jiajing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China"},{"name":"Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"R3-20250504","first-page":"594","article-title":"Chinese expert consensus on intravascular treatment of symptomatic intracranial atherosclerotic stenosis 2018 (in Chinese)","volume":"13","author":"Baomin","year":"2018","journal-title":"Chinese Journal of Stroke"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/STROKEAHA.113.004099","article-title":"Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke","volume":"45","author":"Kwon","year":"2014","journal-title":"Stroke"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/WNL.0000000000000643","article-title":"Neurofluctuation in patients with subcortical ischemic stroke","volume":"83","author":"Vahidy","year":"2014","journal-title":"Neurology"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1161\/STROKEAHA.116.015146","article-title":"20-hydroxyeicosatetraenoic acid as a predictor of neurological deterioration in acute minor ischemic stroke","volume":"47","author":"Yi","year":"2016","journal-title":"Stroke"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s00415-016-8181-5","article-title":"Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population","volume":"263","author":"Yi","year":"2016","journal-title":"J Neurol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.STR.14.3.363","article-title":"Angiographical analysis of acute cerebral infarction followed by \u201ccascade\u201d-like deterioration of minor neurological deficits. What is progressing stroke?","volume":"14","author":"Irino","year":"1983","journal-title":"Stroke"},{"key":"R10-20250504","first-page":"666","article-title":"Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke 2018","volume":"51","author":"Yi","year":"2018","journal-title":"Chin J Neur"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P4502C19 loss-of-function polymorphisms is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/09537104.2014.953044","article-title":"Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel","volume":"26","author":"Sun","year":"2015","journal-title":"Platelets"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3949\/ccjm.78a.10145","article-title":"Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others","volume":"78","author":"Kitzmiller","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/clpt.2011.132","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy","volume":"90","author":"Scott","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","article-title":"A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants","volume":"79","author":"Sarah","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R16-20250504","first-page":"4","article-title":"New Castle-Ottawa Quality Assessment Scale- -Cohort Studies","volume":"15","author":"Wells","year":"2012","journal-title":"Clin Epidemiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00228-018-2468-7","article-title":"Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19 \u22172 reduced- function alleles","volume":"74","author":"Lin","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2010\/123903","article-title":"The NIHSS-plus: improving cognitive assessment with the NIHSS","volume":"22","author":"Gottesman","year":"2010","journal-title":"Behav Neurol"},{"key":"R19-20250504","first-page":"1026","article-title":"The NIHSS Score and its Components can Predict Cortical Stroke","volume":"2","author":"Sartor","year":"2013","journal-title":"J Neurol Disord Stroke"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2014.11.037","article-title":"Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel","volume":"747","author":"Qiu","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"R23-20250504","first-page":"854","article-title":"Relationship between clopidogrel response, early neurological deterioration and CYP2C19 gene polymorphisms in symptomatic intracranial atherosclerotic stenosis (sICAS) patients","volume":"38","author":"Gao","year":"2017","journal-title":"Journal of Sun Yat-Sen University"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00415-018-8998-1","article-title":"Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19\u22172 reduced-function alleles","volume":"265","author":"Xingyang","year":"2018","journal-title":"J Neurol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.5551\/jat.33290","article-title":"Association of cytochrome P450 genetic variants with clopidogrel resistance and outcomes in acute ischemic stroke","volume":"23","author":"Xingyang","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/STROKEAHA.113.000823","article-title":"CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China","volume":"44","author":"Jia","year":"2013","journal-title":"Stroke"},{"key":"R27-20250504","first-page":"1131","article-title":"Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19\u22172 reduced-function alleles","volume":"74","author":"Jing","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jns.2016.08.025","article-title":"Effect of CYP2C19\u22172 and \u22173 on clinical outcome in ischemic stroke patients treated with clopidogrel","volume":"369","author":"Wang","year":"2016","journal-title":"J Neurol Sci"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41401-018-0178-4","article-title":"Influences of an NR1I2 polymorphisms on heterogeneous antiplatelet reactivity responses to clopidogrel and clinical outcomes in acute ischemic stroke patients","volume":"40","author":"Chen","year":"2019","journal-title":"Acta Pharmacologica Sinica"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.001","article-title":"Concomitant use of proton pump inhibitors and clopidogrel is not associated with adverse outcomes after ischemic stroke in Chinese population","volume":"25","author":"Yi","year":"2016","journal-title":"Stroke Cerebrovasc Dis"},{"key":"R31-20250504","first-page":"AS02","article-title":"Association between CYP2C19 genetic polymorphisms and clinical outcome in acute atherothrombotic stroke: a sub-analysis of the praise study","volume":"2(IS) 98\u2013476","author":"Fukuma","year":"2017","journal-title":"Eur Stroke J"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.014","article-title":"CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel","volume":"24","author":"Jeong","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R33-20250504","first-page":"871","article-title":"Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian","volume":"32","author":"Fang","year":"2015","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/STROKEAHA.107.502807","article-title":"Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project","volume":"39","author":"Zhao","year":"2008","journal-title":"Stroke"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.06.008","article-title":"Reduced clopidogrel metabolism in a multiethnic population: prevalence and rates of recurrent cerebrovascular events","volume":"23","author":"Spokoyny","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3171\/2015.6.JNS15795","article-title":"CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease","volume":"124","author":"Hoh","year":"2016","journal-title":"J Neurosurg"},{"key":"R37-20250504","first-page":"6","article-title":"Association of CYP2C19 polymorphisms with the clinical efficacy of clopidogrel therapy in patients undergoing carotid artery stenting in Asia","volume":"3","author":"Zhu","year":"2016","journal-title":"Sci Rep"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.5551\/jat.33290","article-title":"Association of cytochrome P450 genetic variants with clopidogrel resistance and outcomes in acute ischemic stroke","volume":"23","author":"Yi","year":"2016","journal-title":"J Atheroscler Thromb"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:28:25Z","timestamp":1746325705000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025150"}},"subtitle":["A systematic review and meta-analysis of prospective cohort studies"],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025150","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"2019-11-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}